T1	p 44 75	children with acute diarrhoea .
T2	p 192 207	acute childhood
T3	p 333 364	children with acute diarrhoea .
T4	p 373 398	Two hundred children were
T5	p 1554 1562	children
T6	i 17 40	Saccharomyces boulardii
T7	i 113 129	Lactobacillus GG
T8	i 264 289	Saccharomyces boulardii .
T9	i 317 329	S. boulardii
T10	i 421 449	S. boulardii in a granulated
T11	i 474 530	250 mg ( S. boulardii group ) or placebo ( placebo group
T12	i 757 769	S. boulardii
T13	i 788 795	placebo
T14	i 876 885	boulardii
T15	i 910 917	placebo
T16	i 968 980	S. boulardii
T17	i 1109 1118	boulardii
T18	i 1137 1144	placebo
T19	i 1205 1212	placebo
T20	i 1253 1262	boulardii
T21	i 1311 1329	placebo-controlled
T22	i 1351 1363	S. boulardii
T23	i 1454 1466	S. boulardii
T24	o 143 151	efficacy
T25	o 648 655	medians
T26	o 663 686	average stool frequency
T27	o 822 857	duration of diarrhoea significantly
T28	o 968 1016	S. boulardii on watery diarrhoea became apparent
T29	o 1061 1086	duration of hospital stay
T30	o 1273 1295	persisting diarrhoea .
T31	o 1390 1421	duration of acute diarrhoea and
T32	o 1426 1453	duration of hospital stay .
T33	o 1535 1550	acute diarrhoea